These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 104641)

  • 41. Prospective use of intramuscular triamcinolone acetonide in pseudogout.
    Roane DW; Harris MD; Carpenter MT; Finger DR; Jarek MJ; Alloway JA; Erickson AR; Venanzi WE; Drehmer TJ
    J Rheumatol; 1997 Jun; 24(6):1168-70. PubMed ID: 9195527
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of intranasal triamcinolone acetonide with oral loratadine in the treatment of seasonal ragweed-induced allergic rhinitis.
    Gawchik SM; Lim J
    Am J Manag Care; 1997 Jul; 3(7):1052-8. PubMed ID: 10173369
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Short-term clinical evaluation of intralesional triamcinolone acetonide injection for ulcerative oral lichen planus.
    Xia J; Li C; Hong Y; Yang L; Huang Y; Cheng B
    J Oral Pathol Med; 2006 Jul; 35(6):327-31. PubMed ID: 16762012
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A short-term double-blind trial of aerosol triamcinolone acetonide in steroid-dependent patients with severe asthma.
    Kriz RJ; Chmelik F; doPico G; Reed CE
    Chest; 1976 Apr; 69(4):455-60. PubMed ID: 770091
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of asthma with triamcinolone acetonide aerosol.
    Williams MH
    Chest; 1975 Dec; 68(6):765-8. PubMed ID: 1192852
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adrenal function in adult asthmatics during long-term daily treatment with 800, 1,200, and 1,600 micrograms triamcinolone acetonide. Multicenter study.
    Altman LC; Findlay SR; Lopez M; Lukacsko P; Morris RJ; Pinnas JL; Ratner PH; Szefler SJ; Welch MJ
    Chest; 1992 May; 101(5):1250-6. PubMed ID: 1582280
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A one-year trial of triamcinolone acetonide aerosol in severe steroid-dependent asthma.
    Kriz RJ; Chmelik F; doPico G; Reed CE
    Chest; 1977 Jul; 72(1):36-44. PubMed ID: 872652
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effects of triamcinolone acetonide on the voice.
    Watkin KL; Ewanowski SJ
    J Speech Hear Res; 1979 Sep; 22(3):446-55. PubMed ID: 502506
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Triamcinolone acetonide (kenalog) in the treatment of chronic bronchitis and bronchial asthma].
    Ajewski Z; Droszcz W; Madalińska M
    Pol Arch Med Wewn; 1972 Nov; 49(5):493-8. PubMed ID: 4643104
    [No Abstract]   [Full Text] [Related]  

  • 50. [Effect of triamcinolone acetonide on the phagocytic capacity of isolated human peripheral granulocytes].
    Chazan R; Droszcz W
    Pol Arch Med Wewn; 1983 Jan; 69(1):21-7. PubMed ID: 6889143
    [No Abstract]   [Full Text] [Related]  

  • 51. [Hemorrhagic diathesis caused by mesenchymo-capillary changes in patients with bronchial asthma chronically treated with triamcinolone acetonide].
    Obtułowicz K; Chłap Z
    Pol Arch Med Wewn; 1982 Apr; 67(4):177-82. PubMed ID: 7134024
    [No Abstract]   [Full Text] [Related]  

  • 52. Long-term corticosteroid (corticoid) therapy in the chronic asthmatic patient.
    TUFT L
    Am J Med Sci; 1962 Dec; 244():686-95. PubMed ID: 13994718
    [No Abstract]   [Full Text] [Related]  

  • 53. Hepatic abnormalities associated with long-term use of troleandomycin in asthma: a case report.
    Dasgupta A; Marcoux JP
    Ann Allergy; 1978 Nov; 41(5):297-8. PubMed ID: 102222
    [No Abstract]   [Full Text] [Related]  

  • 54. Relationship between the usability and physicochemical properties of triamcinolone acetonide ointments.
    Inoue Y; Maeda R; Furuya K; Isamu M; Masayuki K; Kanamoto I
    Results Pharma Sci; 2013; 3():15-9. PubMed ID: 25756000
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Adrenocortical function in bronchial asthma].
    GAMBARO GC; POLLERI A; LOTTI G
    Arch Maragliano Patol Clin; 1962 Aug; 18():473-500. PubMed ID: 13946318
    [No Abstract]   [Full Text] [Related]  

  • 56. Adrenal responses to a low-dose short synacthen test in children with asthma.
    Hawcutt DB; Jorgensen AL; Wallin N; Thompson B; Peak M; Lacy D; Newland P; Didi M; Couriel J; Blair J; Pirmohamed M; Smyth RL
    Clin Endocrinol (Oxf); 2016 May; 84(5):793. PubMed ID: 27043153
    [No Abstract]   [Full Text] [Related]  

  • 57. A survey of United States dermatologists' knowledge, attitudes, and practices with intramuscular triamcinolone.
    Kuceki G; Snyder AM; Hopkins ZH; Secrest AM
    Arch Dermatol Res; 2023 Sep; 315(7):1995-2002. PubMed ID: 36871253
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Systemic glucocorticoid therapy and adrenal insufficiency in adults: A systematic review.
    Joseph RM; Hunter AL; Ray DW; Dixon WG
    Semin Arthritis Rheum; 2016 Aug; 46(1):133-41. PubMed ID: 27105755
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of oral prednisolone and intramuscular depot triamcinolone in patients with severe chronic asthma.
    Droszcz W; Piotrowska B
    Thorax; 1985 Mar; 40(3):207-8. PubMed ID: 3983891
    [No Abstract]   [Full Text] [Related]  

  • 60. Assessment of adrenocortical function in asthmatic patients on long-term triamcinolone acetonide treatment.
    Droszcz W; Malunowicz E; Lech B; Krawczynska H; Madalinska M
    Ann Allergy; 1979 Jan; 42(1):41-3. PubMed ID: 104641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.